ScholarIQanswers from OpenAlex & ORCID
Elizabeth M. Jaffee
ResearcherPublications, citations & collaboration network
Elizabeth M. Jaffee is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Elizabeth M. Jaffee have?
ScholarIQindexed works
Elizabeth M. Jaffee has 1,442 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Elizabeth M. Jaffee have?
ScholarIQcitation count
Elizabeth M. Jaffee has 57,617 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Elizabeth M. Jaffee?
ScholarIQh-index
Elizabeth M. Jaffee has an h-index of 112 in OpenAlex.
What is the i10-index of Elizabeth M. Jaffee?
ScholarIQi10-index
Elizabeth M. Jaffee has an i10-index of 343 in OpenAlex.
What is the ORCID of Elizabeth M. Jaffee?
ScholarIQorcid
The ORCID for Elizabeth M. Jaffee is on the source record.
What is the OpenAlex record for Elizabeth M. Jaffee?
ScholarIQopenalex
The OpenAlex for Elizabeth M. Jaffee is on the source record.
What are the most-cited papers on Elizabeth M. Jaffee?
ScholarIQmost cited works
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Siân Jones, Xiaosong Zhang, D. Williams Parsons, Jimmy Lin, Rebecca Leary, Philipp Angenendt, Parminder K. Mankoo, Hannah Carter, Hirohiko Kamiyama, Antonio Jimeno, Seung‐Mo Hong, Baojin Fu, Ming‐Tseh Lin, Eric S. Calhoun, Mihoko Kamiyama, Kimberly Walter, Tatiana Nikolskaya, Yuri Nikolsky, James Hartigan, Douglas R. Smith, Manuel Hidalgo, Steven D. Leach, Alison P. Klein, Elizabeth M. Jaffee, Michael Goggins, Anirban Maitra, Christine A. Iacobuzio–Donahue, James R. Eshleman, Scott E. Kern, Ralph H. Hruban, Rachel Karchin, Nickolas Papadopoulos, Giovanni Parmigiani, Bert Vogelstein, Victor E. Velculescu, Kenneth W. Kinzler
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
Timothy A. Chan, Mark Yarchoan, Elizabeth M. Jaffee, Charles Swanton, Sergio A. Quezada, Albrecht Stenzinger, Solange Peters
Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi, Tim F. Greten, Todd S. Crocenzi, Gregory M. Springett, Michael A. Morse, Herbert J. Zeh, Deirdre Jill Cohen, Robert L. Fine, Beth Onners, Jennifer N. Uram, Daniel A. Laheru, Eric R. Lutz, Sara Solt, Aimee Murphy, Justin Skoble, Ed Lemmens, John Grous, Thomas W. Dubensky, Dirk G. Brockstedt, Elizabeth M. Jaffee
A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma
Lutz Eric, Charles J. Yeo, Keith D. Lillemoe, Barbara Biedrzycki, Barry Kobrin, Joseph M. Herman, Elizabeth A. Sugar, Steven Piantadosi, John L. Cameron, Sara Solt, Beth Onners, Irena Tartakovsky, Miri Choi, Rajni Sharma, Peter B. Illei, Hruban Ralph H., Ross A. Abrams, Dung T. Le, Elizabeth M. Jaffee, Dan Laheru
A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
Dung T. Le, Dirk G. Brockstedt, Ran Nir‐Paz, Johannes Hampl, Shruti Mathur, John Nemunaitis, Daniel H. Sterman, Raffit Hassan, Eric R. Lutz, Bentley Moyer, Martin Giedlin, Jana-Lynn Louis, Elizabeth A. Sugar, Alice Pons, Andrea L. Cox, Jordana Levine, Aimee Murphy, Peter B. Illei, Thomas W. Dubensky, Joseph E. Eiden, Elizabeth M. Jaffee, Daniel A. Laheru